Justin G. Shaka BA, MBA

Mr. Shaka is Co-founder and CEO or REBIScan, a Cambridge, Massachusetts startup specializing in ocular scanning devices. REBIScan’s first product is the Pediatric Vision Scanner, which is designed to detect amblyopia and strabismus, the leading causes of preventable vision loss worldwide. Through management of the regulatory, reimbursement, and manufacturing processes, Mr. Shaka has become a leader in the medical optics space. Prior to founding REBIScan, Mr. Shaka served as financial analyst for Children’s Hospital Ophthalmology Foundation at Boston Children’s Hospital. In this role, he managed over $25 million in funds, including those of the lab for Dr. David Hunter, codeveloper of the Pediatric Vision Scanner as well as Mr. Shaka’s co-founder at REBIScan. Mr. Shaka is a Phi Beta Kappa graduate of the University of New Hampshire with a degree in Economics, and received his MBA from the Tepper School of Business at Carnegie Mellon University. In 2011, Mr. Shaka was named Carnegie Mellon’s Canfield-Roseman Entrepreneur of the Year.